NVST or ABT: Which Is the Better Value Stock Right Now?
In a comparison of two Medical Products stocks, Envista (NVST) emerges as the superior value option over Abbott (ABT). NVST holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a lower forward P/E ratio of 17.51 and PEG ratio of 1.28. ABT has a Zacks Rank #3 (Hold) with a Value grade of C, with higher valuations at P/E of 19.11 and PEG of 1.96. Based on stronger earnings outlook and more attractive valuation metrics, NVST is positioned as the better value investment.